Literature DB >> 17360675

Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells.

Jun Urano1, Tatsuhiro Sato, Tomohiko Matsuo, Yoko Otsubo, Masayuki Yamamoto, Fuyuhiko Tamanoi.   

Abstract

Rheb is a unique member of the Ras superfamily GTP-binding proteins. We as well as others previously have shown that Rheb is a critical component of the TSC/TOR signaling pathway. In fission yeast, Rheb is encoded by the rhb1 gene. Rhb1p is essential for growth and directly interacts with Tor2p. In this article, we report identification of 22 single amino acid changes in the Tor2 protein that enable growth in the absence of Rhb1p. These mutants also exhibit decreased mating efficiency. Interestingly, the mutations are located in the C-terminal half of the Tor2 protein, clustering mainly within the FAT and kinase domains. We noted some differences in the effect of a mutation in the FAT domain (L1310P) and in the kinase domain (E2221K) on growth and mating. Although the Tor2p mutations bypass Rhb1p's requirement for growth, they are incapable of suppressing Rhb1p's requirement for resistance to stress and toxic amino acids, pointing to multiple functions of Rhb1p. In mammalian systems, we find that mammalian target of rapamycin (mTOR) carrying analogous mutations (L1460P or E2419K), although sensitive to rapamycin, exhibits constitutive activation even when the cells are starved for nutrients. These mutations do not show significant difference in their ability to form complexes with Raptor, Rictor, or mLST8. Furthermore, we present evidence that mutant mTOR can complex with wild-type mTOR and that this heterodimer is active in nutrient-starved cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360675      PMCID: PMC1805553          DOI: 10.1073/pnas.0608510104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  An activated mTOR mutant supports growth factor-independent, nutrient-dependent cell survival.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Oncogene       Date:  2004-07-22       Impact factor: 9.867

2.  Random mutagenesis of gene-sized DNA molecules by use of PCR with Taq DNA polymerase.

Authors:  Y H Zhou; X P Zhang; R H Ebright
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

3.  Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.

Authors:  K Hara; K Yonezawa; Q P Weng; M T Kozlowski; C Belham; J Avruch
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

Review 4.  mTOR, translational control and human disease.

Authors:  Andrew R Tee; John Blenis
Journal:  Semin Cell Dev Biol       Date:  2004-12-31       Impact factor: 7.727

5.  The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus.

Authors:  G J Brunn; P Fadden; T A Haystead; J C Lawrence
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

6.  Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling.

Authors:  D M Sabatini; R K Barrow; S Blackshaw; P E Burnett; M M Lai; M E Field; B A Bahr; J Kirsch; H Betz; S H Snyder
Journal:  Science       Date:  1999-05-14       Impact factor: 47.728

Review 7.  Recent advances in the regulation of the TOR pathway by insulin and nutrients.

Authors:  Joseph Avruch; Yenshou Lin; Xiaomeng Long; Sid Murthy; Sara Ortiz-Vega
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-01       Impact factor: 4.294

Review 8.  Dysregulation of the TSC-mTOR pathway in human disease.

Authors:  Ken Inoki; Michael N Corradetti; Kun-Liang Guan
Journal:  Nat Genet       Date:  2005-01       Impact factor: 38.330

9.  Amino acid availability regulates p70 S6 kinase and multiple translation factors.

Authors:  X Wang; L E Campbell; C M Miller; C G Proud
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

10.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Authors:  Estela Jacinto; Robbie Loewith; Anja Schmidt; Shuo Lin; Markus A Rüegg; Alan Hall; Michael N Hall
Journal:  Nat Cell Biol       Date:  2004-10-03       Impact factor: 28.824

View more
  78 in total

1.  TOR complex 2 (TORC2) in Dictyostelium suppresses phagocytic nutrient capture independently of TORC1-mediated nutrient sensing.

Authors:  Daniel Rosel; Taruna Khurana; Amit Majithia; Xiuli Huang; Ramanath Bhandari; Alan R Kimmel
Journal:  J Cell Sci       Date:  2012-01-20       Impact factor: 5.285

2.  Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.

Authors:  Hongyu Zhou; Chaowei Shang; Min Wang; Tao Shen; Lingmei Kong; Chunlei Yu; Zhennan Ye; Yan Luo; Lei Liu; Yan Li; Shile Huang
Journal:  Biochem Pharmacol       Date:  2016-07-07       Impact factor: 5.858

3.  AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth.

Authors:  Sang Ryong Kim; Tatyana Kareva; Olga Yarygina; Nikolai Kholodilov; Robert E Burke
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

Review 4.  Molecular mechanisms underlying the mitosis-meiosis decision.

Authors:  Yuriko Harigaya; Masayuki Yamamoto
Journal:  Chromosome Res       Date:  2007       Impact factor: 5.239

5.  IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.

Authors:  Michal Marzec; Xiaobin Liu; Monika Kasprzycka; Agnieszka Witkiewicz; Puthiyaveettil N Raghunath; Mouna El-Salem; Erle Robertson; Niels Odum; Mariusz A Wasik
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

6.  Isp7 is a novel regulator of amino acid uptake in the TOR signaling pathway.

Authors:  Dana Laor; Adiel Cohen; Metsada Pasmanik-Chor; Varda Oron-Karni; Martin Kupiec; Ronit Weisman
Journal:  Mol Cell Biol       Date:  2013-12-16       Impact factor: 4.272

7.  TORC2 is required to maintain genome stability during S phase in fission yeast.

Authors:  Miriam Schonbrun; Masha Kolesnikov; Martin Kupiec; Ronit Weisman
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

8.  Mutations in critical domains confer the human mTOR gene strong tumorigenicity.

Authors:  Avaniyapuram Kannan Murugan; Ali Alzahrani; Mingzhao Xing
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

9.  Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.

Authors:  Tatsuhiro Sato; Akio Nakashima; Lea Guo; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

Review 10.  Signaling cascades as drug targets in model and pathogenic fungi.

Authors:  Robert J Bastidas; Jennifer L Reedy; Helena Morales-Johansson; Joseph Heitman; Maria E Cardenas
Journal:  Curr Opin Investig Drugs       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.